search
Back to results

Study on Adhesion Properties of Three Different Adhesives

Primary Purpose

Healthy

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Application of adhesive
Sponsored by
Ambu A/S
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Healthy

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Female Healthy Volunteers.
  • Age 18 - 40 years old.
  • Willing to attend two scheduled visits
  • Able to assess itch and adherence at 24h, 48h and 72h.
  • Provide written informed consent.

Exclusion Criteria:

  • Non-intact skin barrier (e.g. eczema, rash, cut, scar tissue, wound, etc.).
  • History of inflammatory skin diseases (e.g. atopic dermatitis or psoriasis).
  • History of contact allergy
  • Swimming or engaging in sport activities causing sweat during study peri-od. v. Use of medication (e.g. corticosteroids) which could affect skin reactions.

Sites / Locations

  • Gentofte Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Adhesive 1

Adhesive 2

Adhesive 3

Arm Description

This arm investigates one type of silicone adhesive (3M2475P) on adult female skin.

This arm investigates one type of silicone adhesive (RX1449P) on adult female skin.

This arm investigates one type of silicone adhesive (PS-1243) on adult female skin.

Outcomes

Primary Outcome Measures

Skin adhesion rating
Rate of adhesion on a 5-point scale (no lift off the skin to deattached and completely off the skin)

Secondary Outcome Measures

Itch
Subject evaluation of itch during removal measured on visual analogue scale (0-10)
Ease of removal
Ease of removal on 5-point scale (very difficult to very easy)
Pain during removal of adhesive
Subject evaluation of pain during removal measured on visual analogue scale (0-10)
Rate of skin reaction
Skin reaction rated on a scale from 0-7 (no evidence of irritation to strong reaction spreading beyond the application site)
Adhesive residue
Adhesioe residue left on skin after removal of adhesive (yes/no)

Full Information

First Posted
October 11, 2019
Last Updated
November 18, 2019
Sponsor
Ambu A/S
search

1. Study Identification

Unique Protocol Identification Number
NCT04125797
Brief Title
Study on Adhesion Properties of Three Different Adhesives
Official Title
A Single Centre Comparison Study on Adhesion Properties of Three (3) Skin Adhesives on Healthy, Female, Adult Volunteers
Study Type
Interventional

2. Study Status

Record Verification Date
November 2019
Overall Recruitment Status
Completed
Study Start Date
October 7, 2019 (Actual)
Primary Completion Date
October 31, 2019 (Actual)
Study Completion Date
October 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ambu A/S

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This clinical investigation is a single centre, double blinded, case control study in healthy adult females. This study will be conducted in private rooms at Gentofte Hospital (Hjerte-medicinsk Forskning, post 835, Kildegårdsvej 28, 2900 Hellerup). The investigation centre will enroll 39 subjects including a 20% drop out within a four (4) months period. The subject will not be enrolled before approval of investigation protocol by the local ethics committee. The subjects need to meet the inclusion and exclusion criteria to be included in this clinical investigation. Each volunteer enrolled in the investigation can only participate once in a procedure. The testing period for each subject will be minimum 72 hours. The principal investigator's qualifications will be verified through his/her CV. The principal investigator is required to be a medical doctor with at least one year's experience in using similar medical adhesives (e.g. by being experienced in using electrodes where medical adhesives are included) and at least one year's experience with clinical research. In addition, the investigator must be trained in GCP before the study is initiated. If any subject withdraws from the study, they will not be replaced as drop-out rate is included in the sample size. Subjects must show up for two sessions, in the first session six adhesives will be placed below the subjects bra. The adhesives will be removed after minimum 72 hours at the second visit. While wearing the adhesives the subjects must keep the investigational area dry. 24, 48 and 72 hours after placement of the adhesives, the subject is asked to completed a questionnaire. The eCRF must be completed for each subject that has signed the Informed consent form (ICF) and enrolled into this clinical investigation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
39 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Adhesive 1
Arm Type
Active Comparator
Arm Description
This arm investigates one type of silicone adhesive (3M2475P) on adult female skin.
Arm Title
Adhesive 2
Arm Type
Active Comparator
Arm Description
This arm investigates one type of silicone adhesive (RX1449P) on adult female skin.
Arm Title
Adhesive 3
Arm Type
Active Comparator
Arm Description
This arm investigates one type of silicone adhesive (PS-1243) on adult female skin.
Intervention Type
Other
Intervention Name(s)
Application of adhesive
Intervention Description
Adhesive will be placed on the subjects skin below the bra. Placement of the adhesive will be randomized.
Primary Outcome Measure Information:
Title
Skin adhesion rating
Description
Rate of adhesion on a 5-point scale (no lift off the skin to deattached and completely off the skin)
Time Frame
Minimum 72 hours after application
Secondary Outcome Measure Information:
Title
Itch
Description
Subject evaluation of itch during removal measured on visual analogue scale (0-10)
Time Frame
24, 48 and 72 hours after adsive application
Title
Ease of removal
Description
Ease of removal on 5-point scale (very difficult to very easy)
Time Frame
Minimum 72 hours after application
Title
Pain during removal of adhesive
Description
Subject evaluation of pain during removal measured on visual analogue scale (0-10)
Time Frame
Minimum 72 hours after application
Title
Rate of skin reaction
Description
Skin reaction rated on a scale from 0-7 (no evidence of irritation to strong reaction spreading beyond the application site)
Time Frame
Minimum 72 hours after application
Title
Adhesive residue
Description
Adhesioe residue left on skin after removal of adhesive (yes/no)
Time Frame
Minimum 72 hours after application

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Female Healthy Volunteers. Age 18 - 40 years old. Willing to attend two scheduled visits Able to assess itch and adherence at 24h, 48h and 72h. Provide written informed consent. Exclusion Criteria: Non-intact skin barrier (e.g. eczema, rash, cut, scar tissue, wound, etc.). History of inflammatory skin diseases (e.g. atopic dermatitis or psoriasis). History of contact allergy Swimming or engaging in sport activities causing sweat during study peri-od. v. Use of medication (e.g. corticosteroids) which could affect skin reactions.
Facility Information:
Facility Name
Gentofte Hospital
City
Hellerup
ZIP/Postal Code
2900
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Study on Adhesion Properties of Three Different Adhesives

We'll reach out to this number within 24 hrs